Actuate Therapeutics Stock (NASDAQ: ACTU) stock price, news, charts, stock research, profile.
You can purchase shares of Actuate Therapeutics (NASDAQ:ACTU) through any online brokerage.
Other companies in Actuate Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Renovaro (NASDAQ:RENB), Innate Pharma (NASDAQ:IPHA), Monopar Therapeutics (NASDAQ:MNPR) and Aligos Therapeutics (NASDAQ:ALGS).
There is no analysis for Actuate Therapeutics to provide a consensus price target.
The stock price for Actuate Therapeutics (NASDAQ: ACTU) is $8 last updated January 8, 2025 at 4:00 PM EST.
There are no upcoming dividends for Actuate Therapeutics.
Actuate Therapeutics’s Q4 earnings are confirmed for Friday, February 21, 2025.
There is no upcoming split for Actuate Therapeutics.
Actuate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.